All Articles
Browse the full archive, newest first.
FDA's Proposal on Obesity Drugs Raises Industry Concerns Amid AstraZeneca Setbacks
The FDA's recent proposal to exclude active ingredients in obesity drugs from the compounding list has sparked significant concerns within the industry, coinciding with AstraZeneca's challenges in drug development.
Editorial Staff May 1
Evaluating Energy Fuels: A Potential Investment Amid U.S. Energy Security Concerns
With ongoing discussions about U.S. energy security, investors are considering the implications of investing in Energy Fuels, a uranium mining company.
Editorial Staff May 1